CTOs on the Move

AbsoluteCare

www.absolutecare.com

 
We are passionate about our work and compassionate toward our people, whether they work here or seek care from us. We opened the first AbsoluteCare center in Atlanta in 2000, with a primary focus on treating members with HIV/AIDS. We quickly became an HIV Center of Excellence, achieving impressive results: an 88 percent retention rate and a 97 percent undetectable rate. A surprising thing happened. With so many of them free of the symptoms of HIV/AIDS, our members sought primary care from us. They were coming in for help controlling asthma, diabetes, heart disease, hypertension, and all the other conditions ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Rob Posner
Chief Technology Officer Profile

Funding

AbsoluteCare raised $105M on 01/07/2021

Similar Companies

Johnson's Medical

Johnson's Medical is a Lehi, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jj Medical System

Jj Medical System is a Bingham Farms, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Univac Precision

Univac Precision is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

SpineFrontier

SpineFrontier Inc. is a growing medical device company that designs, develops and markets implants and instruments that equip surgeons to perform the least invasive spine surgery. SpineFrontier`s innovative and disruptive technologies and techniques apply the Less Exposure Surgery (LES) philosophy to solve clinical problems and make the surgeries safer for the patient and easier for the surgeon. Surgeries can be done in an outpatient center and patients can be discharged same day with rapid recovery, due to less disruption of normal tissues and less time in surgery. We believe LESS is more. LESS time in treatment and recovery is MORE time in action for our patients and surgeons. SpineFrontier is headquartered in Beverly, Massachusetts. It was founded in 2006, and released its first products in 2008. SpineFrontier is a KICventures portfolio company and the exclusive manufacturer of LESS technologies and instruments for surgeon members practicing in the LESS Institute global outpatient network.